These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18505395)

  • 21. Probing the surface of Neisseria gonorrhoeae: simultaneous localization of protein I and H.8 antigens.
    Robinson EN; McGee ZA; Buchanan TM; Blake MS; Hitchcock PJ
    Infect Immun; 1987 May; 55(5):1190-7. PubMed ID: 3106215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae.
    Hadad R; Jacobsson S; Pizza M; Rappuoli R; Fredlund H; Olcén P; Unemo M
    APMIS; 2012 Sep; 120(9):750-60. PubMed ID: 22882265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal Antibodies.
    Beernink PT; Ispasanie E; Lewis LA; Ram S; Moe GR; Granoff DM
    J Infect Dis; 2019 Mar; 219(7):1130-1137. PubMed ID: 30346576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential impact of vaccination on the prevalence of gonorrhea.
    Craig AP; Gray RT; Edwards JL; Apicella MA; Jennings MP; Wilson DP; Seib KL
    Vaccine; 2015 Aug; 33(36):4520-4525. PubMed ID: 26192351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice.
    Price GA; Masri HP; Hollander AM; Russell MW; Cornelissen CN
    Vaccine; 2007 Oct; 25(41):7247-60. PubMed ID: 17720283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Problems posed by potential gonococcal vaccines viewed from the vantage point of a control agency.
    Robbins JB
    Br J Vener Dis; 1977 Jun; 53(3):170-2. PubMed ID: 406011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The
    Jen FE; Semchenko EA; Day CJ; Seib KL; Jennings MP
    Front Immunol; 2019; 10():137. PubMed ID: 30787927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antigenic composition of the gonococcal strains used in preparing a gonorrhea vaccine].
    Andreeva ZM; Shevchenko NM
    Vestn Dermatol Venerol; 1986; (7):33-5. PubMed ID: 3094267
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serotyping Neisseria gonorrhoeae].
    Kohl PK; Petzoldt D
    Hautarzt; 1987 Jan; 38(1):4-9. PubMed ID: 2435677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccines for gonorrhea: where are we on the curve?
    Blake MS; Wetzler LM
    Trends Microbiol; 1995 Dec; 3(12):469-74. PubMed ID: 8800838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common heat stable protective antigen in gonococci.
    Ito JI; Corbeil LB; Wunderlich AC; McCutchan JA; Braude AI
    Trans Assoc Am Physicians; 1979; 92():160-8. PubMed ID: 95067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of the Recombinant
    Almonacid-Mendoza HL; Humbert MV; Dijokaite A; Cleary DW; Soo Y; Hung MC; Orr CM; Machelett MM; Tews I; Christodoulides M
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30305317
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation of Naturally Released Gonococcal Outer Membrane Vesicles as Vaccine Antigens.
    Francis IP; Lui X; Wetzler LM
    Methods Mol Biol; 2019; 1997():121-141. PubMed ID: 31119622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The status of vaccines to meningococcal and gonococcal disease.
    Gotschlich EC
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):341-55. PubMed ID: 2870677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development.
    Rice PA; Shafer WM; Ram S; Jerse AE
    Annu Rev Microbiol; 2017 Sep; 71():665-686. PubMed ID: 28886683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.
    Matthias KA; Connolly KL; Begum AA; Jerse AE; Macintyre AN; Sempowski GD; Bash MC
    J Infect Dis; 2022 Feb; 225(4):650-660. PubMed ID: 34498079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of Hybrid Transferrin Binding Protein Antigens for Protection Against Pathogenic Neisseria Species.
    Fegan JE; Calmettes C; Islam EA; Ahn SK; Chaudhuri S; Yu RH; Gray-Owen SD; Moraes TF; Schryvers AB
    Front Immunol; 2019; 10():247. PubMed ID: 30837995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB-dependent outer membrane receptors.
    Cornelissen CN; Biswas GD; Tsai J; Paruchuri DK; Thompson SA; Sparling PF
    J Bacteriol; 1992 Sep; 174(18):5788-97. PubMed ID: 1325963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.
    Jen FE; Ketterer MR; Semchenko EA; Day CJ; Seib KL; Apicella MA; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33758087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap.
    Gottlieb SL; Jerse AE; Delany-Moretlwe S; Deal C; Giersing BK
    Sex Health; 2019 Sep; 16(5):426-432. PubMed ID: 31476278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.